Flynn James E 13D and 13G filings for GeneDx Holdings Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-01 5:11 pm Purchase |
2023-01-31 | 13G | GeneDx Holdings Corp. WGS |
Flynn James E | 1,733,094 7.260% |
1,161,928![]() (+203.43%) |
Filing |
2022-08-17 1:11 pm Purchase |
2022-08-17 | 13G | GeneDx Holdings Corp. WGS |
Flynn James E | 571,166 4.950% |
147,929![]() (+34.95%) |
Filing |
2022-02-11 4:16 pm Purchase |
2021-12-31 | 13G | GeneDx Holdings Corp. WGS |
Flynn James E | 423,237 5.790% |
3,586![]() (+0.85%) |
Filing |
2021-08-02 12:56 pm Purchase |
2021-07-22 | 13G | GeneDx Holdings Corp. WGS |
Flynn James E | 419,651 5.770% |
419,651![]() (New Position) |
Filing |